Agilon Health Inc

AGL NYSE Healthcare & Biotech United States US00857U1079
102.16 $
7.16 %

Agilon Health is an American company specialized in providing healthcare platforms for senior communities.

Price history of Agilon Health Inc
Price history of Agilon Health Inc

Performance & Momentum

6 Months 402.31 %
1 Year 66.98 %
3 Years 82.34 %
5 Years 89.61 %

Strategic Analysis

Agilon Health Inc • 2026

Agilon Health is developing a coordinated care management model for seniors, leveraging primary care physicians to optimize patient navigation within the U.S. healthcare system. Its positioning is based on operational value creation and improved care delivery, but the company remains highly dependent on its ability to turn this model into sustainable profitability.

Strengths
  • Clear niche in care coordination for elderly patients
  • Embedded in primary care physician networks, which can support access and proximity to patients
  • Exposure to a structurally attractive segment driven by population aging
Weaknesses
  • Very poor share price performance historically, a sign of strong market loss of confidence
  • Strategic visibility weakened by the recent shareholder investigation, which may weigh on momentum and governance credibility
  • High dependence on operational execution and cost control in a complex healthcare environment
Momentum

Observed momentum remains very weak despite a recent short-term rebound, suggesting a technical move rather than a genuine underlying trend reversal. The medium- and long-term trend remains clearly negative, and the news flow around a shareholder investigation is adding further pressure on strategic clarity and investor confidence. For retail investors, the case remains speculative: it may offer re-rating potential if operational improvement becomes credible, but the risk profile remains high.

Similar stocks to Agilon Health Inc

Recent News

Agilon Health Inc

Class Action Filed for Losing Agilon Health (AGL) Investors
4 months ago

On February 10, 2026, Glancy Prongay Wolke & Rotter LLP reminded Agilon Health investors of the March 2, 2026 deadline to join a class action lawsuit alleging financial fraud. This announcement comes amid a sharp 13.88% drop in the stock price, reflecting growing market concerns over legal risks facing the company.

Agilon Health Faces NYSE Warning After Stock Slump
7 months ago

Agilon Health (NYSE: AGL) received a non-compliance notice from the New York Stock Exchange as its average stock price fell below $1 over 30 consecutive days, breaching listing requirements. This triggered a 6.8% drop in the stock, following a 13% decline over the week. Despite revenue growth above market average, the company continues to widen its losses, undermining investor confidence and risking delisting if conditions don't improve soon.

Investigation launched into Agilon Health for shareholders
10 months ago

A law firm has announced an investigation into Agilon Health following losses suffered by some shareholders, indicating potential legal or financial issues. This news likely explains the sharp decline in investor confidence despite a recent apparent rise, creating uncertainty about the company’s future. Due to this uncertainty and increased risk, a cautious approach toward the stock is advised.

Agilon Health Falls Sharply Amid Fraud Investigation
10 months ago

Block & Leviton is investigating Agilon Health for potential securities law violations, triggering a steep 25% drop in its stock. This news has clearly shaken investor confidence, leading to a significant correction. Caution is advised given the legal risks and potential impacts on the company.

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone